GARY W PACE Insider Trading $PCRX Pacira BioSciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GARY W PACE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GARY W PACE. GARY W PACE is Director in RESMED INC ($RMD) and Director in Trovagene, Inc. ($XNOM.OB) and Director in Pacira Pharmaceuticals, Inc. ($PCRX).
GARY W PACE in Pacira BioSciences, Inc.
Trading Symbol: PCRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GARY W PACE: Director
Holdings: 129,949 shares
Current Value: $5,425,371
Latest Transaction: Sep 29 2020
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GARY W PACE in Pacira BioSciences, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XNOM.OB, PCRX, RMD
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 29 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 16.67 | 70,000 | 1,166,900 | 0 | |
Sep 29 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 16.67 | 70,000 | 1,166,900 | 129,949 | 59.9 K to 129.9 K (+116.77 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | A | 47.65 | 8,027 | 382,487 | 8,027 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Grant | A | 0.00 | 1,260 | 0 | 59,949 | 58.7 K to 59.9 K (+2.15 %) |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 13.98 | 5,000 | 69,900 | 0 | |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 1.61 | 7,438 | 11,975 | 0 | |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 1.61 | 4,649 | 7,485 | 0 | |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | M | 1.61 | 4,649 | 7,485 | 0 | |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 13.98 | 5,000 | 69,900 | 58,689 | 53.7 K to 58.7 K (+9.31 %) |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 1.61 | 7,438 | 11,975 | 53,689 | 46.3 K to 53.7 K (+16.08 %) |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 1.61 | 4,649 | 7,485 | 46,251 | 41.6 K to 46.3 K (+11.17 %) |
Mar 16 2020 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Buy | M | 1.61 | 4,649 | 7,485 | 41,602 | 37 K to 41.6 K (+12.58 %) |
Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Grant | A | 0.00 | 4,134 | 0 | 36,953 | 32.8 K to 37 K (+12.60 %) |
Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Option Exercise | A | 43.54 | 8,437 | 367,347 | 8,437 | |
Jun 06 2019 | PCRX | Pacira BioSciences ... | PACE GARY W | Director | Grant | A | 0.00 | 4,134 | 0 | 36,953 | 32.8 K to 37 K (+12.60 %) |
Nov 21 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Buy | P | 46.18 | 4,500 | 207,810 | 32,819 | 28.3 K to 32.8 K (+15.89 %) |
Nov 09 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Buy | P | 51.29 | 4,000 | 205,160 | 28,319 | 24.3 K to 28.3 K (+16.45 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 782 | 0 | 24,319 | 23.5 K to 24.3 K (+3.32 %) |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 1,357 | 0 | 23,537 | 22.2 K to 23.5 K (+6.12 %) |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 1,488 | 0 | 22,180 | 20.7 K to 22.2 K (+7.19 %) |
Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 79.43 | 4,000 | 317,720 | 4,000 | |
Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 2,000 | 0 | 20,692 | 18.7 K to 20.7 K (+10.70 %) |
Mar 17 2015 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Buy | P | 93.83 | 1,000 | 93,830 | 18,692 | 17.7 K to 18.7 K (+5.65 %) |
Page: 1